...
首页> 外文期刊>Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen >Oligometastases in gastric and esophageal cancer. Current clinical trials and surgical concepts
【24h】

Oligometastases in gastric and esophageal cancer. Current clinical trials and surgical concepts

机译:胃和食管癌中的脱极体变量酶。 目前的临床试验和手术概念

获取原文
获取原文并翻译 | 示例
           

摘要

There is an increasing role of surgery even in metastatic tumor stages. In colorectal cancer patients with limited metastases, complete cytoreduction is able to offer long-term survival in synchronic as well as metachronic situations. In tumors of the upper gastrointestinal tract (UGIT), however, the impact of surgery in metastatic disease remains to be clarified. Even though several retrospective studies suggest prolonged survival, surgery is not recommended by the current German S3 guidelines for tumors of the UGIT. Appropriate selection of these particular patients that show less aggressive tumor biology will be the primary goal of preoperative evaluation. The results of the prospective randomized RENAISSANCE/FLOT-5 and GASTRIPEC studies are urgently awaited in order to gain more evidence on the impact of surgery in the management of oligometastases of the UGIT and especially on survival.
机译:即使在转移性肿瘤阶段,手术也存在越来越大的作用。 在转移有限的结肠直肠癌患者中,完全细胞载压缩能够在同步调整和均衡情况下提供长期存活。 然而,在上胃肠道(UGIT)的肿瘤中,手术在转移性疾病中的影响仍有澄清。 尽管几种回顾性研究表明延长存活,但目前德国S3肿瘤的肿瘤指南不推荐手术。 Appropriate selection of these particular patients that show less aggressive tumor biology will be the primary goal of preoperative evaluation. 迫切希望获得预期随机文艺复兴/浮饼5和胃脂研究的结果,以获得更多关于手术对UGIT的寡粒子的影响的有证据,特别是对生存率的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号